Predicting Rupture of AAA by Anatomic and Hemodynamic Markers
Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT02463760
Collaborator
(none)
2
1
78.5
0
Study Details
Study Description
Brief Summary
The purpose of the study is to investigate imaging findings, which can help us to predict factors contributing to abdominal aortic aneurysm growth and rupture.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
2 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Predicting Rupture of Abdominal Aortic Aneurysm (AAA) by Anatomic and Hemodynamic Markers From In-vivo and In-vitro Imaging
Actual Study Start Date
:
Aug 1, 2015
Actual Primary Completion Date
:
Feb 14, 2022
Actual Study Completion Date
:
Feb 14, 2022
Outcome Measures
Primary Outcome Measures
- Imaging findings correlating with abdominal aortic aneurysm growth and rupture [1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Individuals between 18 and 80 years old receiving medical care at University of Minnesota Medical Center who have a normal aorta CTA within the previous year
-
Or patients with known AAA with growth rate of 0-0.2 cm/year
-
Or patients with known AAA with growth rate of greater than 0.5 cm/year.
Exclusion Criteria:
-
Subjects with ferromagnetic implants
-
Penile implant
-
Hip replacement
-
History of shrapnel or shot gun injury
-
Body mass index ≥ 30
-
Cardiac pacemakers
-
Severe claustrophobia
-
Large tattoos on the torso
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Minnesota | Minneapolis | Minnesota | United States | 55455 |
Sponsors and Collaborators
- University of Minnesota
Investigators
- Principal Investigator: Michael Rosenberg, MD, University of Minnesota
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT02463760
Other Study ID Numbers:
- 150023
First Posted:
Jun 4, 2015
Last Update Posted:
Mar 18, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: